Selective hormone receptor modulators are designed as ligands to their respective receptors to provide agonist or antagonist action in specific tissues.
Selective Glucocorticoid Receptor Modulator: Introduction
- Selective hormone receptor modulators are designed as ligands to their respective receptors to provide agonist or antagonist action in specific tissues
- These are named selective androgen receptor modulators (SARMs), selective estrogen receptor modulators (SERMs), selective progesterone receptor modulators (SPRMs), and selective glucocorticoid receptor modulators (SGRMs) based on the specific receptor they are designed to affect
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81809
Key Drivers of Global Selective Glucocorticoid Receptor Modulator Market
- The global selective glucocorticoid receptor modulator market is driven by a rise in prevalence of various diseases such as cancer, respiratory disorders, cardiovascular diseases, increase in geriatric population, and surge in focus on development of advanced pharmaceutical products
- According to the World Health Organization, currently, 235 million people across the world are suffering from asthma and 338,000 deaths due to asthma were reported in 2015
- According to the Centers for Disease Control and Prevention (CDC), 1 in 13 people has asthma in the U.S.
- According to Asthma and Allergy Foundation of America, currently, about 6.2 million children aged 18 and younger are suffering from asthma in the U.S. In 2017, 1 in every 12 children had asthma.
- Adoption of respiratory disorder management has been increasing among the geriatric population for the last few years due a rise in prevalence in this age group and the number of difficulties faced by the population in managing the disorders. Additionally, the elderly find it difficult to use handheld inhalers due to physical and cognitive impairment.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=81809
Selective Estrogen Receptor Modulators (SERMs) to be Highly Attractive Segment
- Based on type, the global selective glucocorticoid receptor modulator market can be classified into selective androgen receptor modulators (SARMs), selective estrogen receptor modulators (SERMs), selective progesterone receptor modulators (SPRMs), and selective glucocorticoid receptor modulators (SGRMs)
- The selective estrogen receptor modulators segment is projected to account for a major share of the global selective glucocorticoid receptor modulator market by 2031, owing to increase in incidence of cancer diseases across the globe
Hospitals to be Highly Lucrative Segment
- In terms of end-user, the global selective glucocorticoid receptor modulator market can be categorized into hospitals, clinics, ambulatory surgical centers, and others
- The hospitals segment is anticipated to account for a major share of the global market during the forecast period due to large inventory maintained by hospitals and availability of essential drugs at hospital pharmacies
Pre Book Selective Glucocorticoid Receptor Modulator Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=81809<ype=S
North America to Offer Significant Opportunities in Selective Glucocorticoid Receptor Modulator Market
- In terms of region, the global selective glucocorticoid receptor modulator market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America accounted for a major share of the global market in 2020, owing to an increase in cases of respiratory disease such as asthma, COPD, and allergic rhinitis; rise in the number of FDA approvals for products in different respiratory diseases, and numerous product launches in the U.S. Moreover, increase in concerns about respiratory disease management including prevention, diagnosis, and treatment drives the market in the region.
Key Players Operating in Global Selective Glucocorticoid Receptor Modulator Market
The global selective glucocorticoid receptor modulator market is consolidated, with the presence of international and local players. Key players operating in the global selective glucocorticoid receptor modulator market are:
- Johnson & Johnson
- Pfizer, Inc.
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Sanofi
- AbbVie Inc.
- Takeda Pharmaceutical Company
- GlaxoSmithKline plc
- Teva Pharmaceuticals
More Trending Reports by Transparency Market Research:
Chronic Focal Encephalitis Market: Chronic focal encephalitis (CFE) is an uncommon but deadly inflammatory brain illness in which individuals fight their own immune system. Chronic focal encephalitis is also known as Rasmussen's encephalitis which causes inflammation of brain and can result in the destruction or removal of a portion of the brain in children.
Vildagliptin Market: Vildagliptin is an antihyperglycemic medication that inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme selectively. It is used to treat type 2 diabetes mellitus, which is characterized by impaired GLP-1 production and insulinotropic effects. DPP-4 is inhibited. Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both incretin hormones that stimulate insulin production and control blood glucose levels, are protected from breakdown by vildagliptin. GLP-1 and GIP levels are elevated, which leads to better glycemic control. Vildagliptin has been shown in clinical studies to have a minimal risk of hypoglycemia
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/